BioAtla, Inc.
Develops antibody-based therapeutics activated within the tumor microenvironment.
BCAB | US
Overview
Corporate Details
- ISIN(s):
- US09077B1044
- LEI:
- Country:
- United States of America
- Address:
- 11085 TORREYANA ROAD, 92121 SAN DIEGO
- Website:
- https://www.bioatla.com/
- Sector:
- Manufacturing
Description
BioAtla, Inc. is a clinical-stage biopharmaceutical company that develops novel antibody-based therapeutics for the treatment of solid tumor cancers. The company's core focus is its proprietary Conditionally Active Biologics™ (CAB) platform. This technology is engineered to create protein therapeutics, including monoclonal antibodies, that are activated specifically within the physiological conditions of the tumor microenvironment. The primary goal of this approach is to enhance the therapeutic index of its drugs, making them safer and more effective by concentrating their activity on cancerous cells while minimizing damage to healthy tissue.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioAtla, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioAtla, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioAtla, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
